1. 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. (9th November 2020) Authors: Ackerman, Shelley; Hartmann, Felix; Pearson, Cecelia; Gonzalez, Joseph; Ho, Po Yi; Kimmey, Samuel; Luo, Andrew; Ackerman, Benjamin; Lee, Arthur; Laura, Richard; Paik, Jason; Henning, Karla; Jackson, David; Chapin, Steven; Devens, Bruce; Dornan, David; Bendall, Sean; Engleman, Edgar; Alonso, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. (9th November 2020) Authors: Ackerman, Shelley; Hartmann, Felix; Pearson, Cecelia; Gonzalez, Joseph; Ho, Po Yi; Kimmey, Samuel; Luo, Andrew; Ackerman, Benjamin; Lee, Arthur; Laura, Richard; Paik, Jason; Henning, Karla; Jackson, David; Chapin, Steven; Devens, Bruce; Dornan, David; Bendall, Sean; Engleman, Edgar; Alonso, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗